Middle East & Africa Active Implantable Medical Devices Market Research Report – Segmented By Product & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, Growth Forecast (2024 to 2029)

Updated On: January, 2024
ID: 4856
Pages: 145

MEA Active Implantable Medical Devices Market Size (2023 to 2028)

The size of the Active Implantable Medical Devices Market in the Middle East & Africa is valued at USD 2.21 billion in 2023. It is expected to reach USD 3.11 billion by 2028, to grow at a CAGR of 7.06% during the forecast period.

The increase in the geriatric population is one of the important drivers for the growth of the market. The number of people aged 60 and over is expected to increase from 535 million in 2012 to nearly 1.7 billion in 2050, or around 18% of the world's population. In addition, the increase in chronic diseases coupled with advancements in active implantable medical devices is expected to drive the growth of the regional active implantable medical devices market, which greatly benefits from the increasing prevalence of various chronic diseases, such as cardiovascular and neurological disorders. Consistent product launches and a streamlined approval process also significantly support the growth of this market. The escalating investments and funds to upgrade more latest technological products, the increasing use, and applications of neurostimulators, and the favorable reimbursement scenario of ENT procedures in developed regions are likely to accelerate the active market growth for implantable medical devices around the world. The forecast period 2020-2025. On the other hand, the emerging market offering significant growth will further drive several opportunities, which will lead to the growth of the MEA active implantable medical device market during the forecast period mentioned above.

Problems with using active implantable medical devices, such as device failure and cybersecurity concerns, could hamper the market growth in the near future. The exceeded cost of implants and a recovery scenario unfavorable will likely hamper the development of the active implantable medical devices market during the forecast, as mentioned earlier period. The shortage of qualified professionals and the strong pressure on companies will be a major challenge for the active market for implantable medical devices. Also, regional brands' presence and availability and the challenges they face due to strong or weak competition from local and national brands.

This research report on the MEA Active Implantable Medical Devices Market report has been segmented and sub-segmented into the following categories:

By Product: 

  • Implantable Cardioverter Defibrillators
    • Transvenous Implantable Cardioverter Defibrillators
      • Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
      • Dual-Chamber Implantable Cardioverter Defibrillators
      • Single-Chamber Implantable Cardioverter Defibrillators
    • Subcutaneous Implantable Cardioverter Defibrillator
  • Implantable Cardiac Pacemakers
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders
  • Neurostimulators
    • Spinal Cord Stimulators
    • Deep Brain Stimulators
    • Sacral Nerve Stimulators
    • Vagus Nerve Stimulators
    • Gastric Electrical Stimulators
  • Implantable Hearing Devices
    • Active Hearing Implants
    • Passive Hearing Implants

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, MEA dominates the active implantable medical device market due to its high accessibility to cutting edge technologies, growing development of innovative and technologically advanced products, and increasing healthcare spending in the region, while the Asia Pacific is expected to grow at the same time highest growth rate in the forecast period from 2023 to 2028 due to the increasing incidence of chronic diseases, increased health spending, health reforms for infrastructure development, increasing demand for advanced technologies to develop advanced products and less stringent regulations. MEA has dominated a significant share of the region implantable and survival device market. The greater participation of the MEA is mainly attributed to the geriatric population's growth, the increase in the prevalence of cardiovascular and neurological diseases, the high accessibility to advanced technologies, the increase in the development of innovative and technologically advances, and increased health spending in the region.

Key Market Players:

Noteworthy companies leading the Middle East & Africa Active Implantable Medical Devices Market Profiled in the Report are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC., Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, and Nurotron Biotechnology Co. Ltd.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample